Cancer News and Research

Latest Cancer News and Research

UC Berkeley, UCSF researchers team up to create center for neurodegenerative disease research

Researchers at UC San Francisco and UC Berkeley have teamed up to create an innovative, integrated center for research on neurodegenerative diseases. Supported by a $3 million grant from the Glenn Foundation for Medical Research, the new center aims to pave the way to developing novel treatments for diseases such as Alzheimer's disease and Parkinson's disease by investigating the many ways that proteins can malfunction within cells.

10 Oct 2014

DU/ER Denim introduces first ever jean with radioactive cell phone protection

Avoid the electromagnetic danger of keeping your cellphone in your pocket; denim brand launches first ever jean with radioactive cell phone protection –to protect your vital organs.

9 Oct 2014

VolitionRx announces additional colorectal cancer data at International Conference of Anticancer Research

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests, today announced that further data analysis from its colorectal cancer study was presented today at the 9th International Conference of Anticancer Research, being held October 6-10, 2014 in Sithonia, Greece.

9 Oct 2014

Study shows rats, mice perform similarly in cognitive tests; offers implications for cognition research

It's one of those ideas that seems to make perfect sense: the bigger the brain, the more intelligent the creature.

9 Oct 2014

CTCs in blood of metastatic cancer patients give genomic read-out of breast cancer

The genetic fingerprint of a metastatic cancer is constantly changing, which means that the therapy that may have stopped a patient's cancer growth today, won't necessarily work tomorrow.

9 Oct 2014

Neuroscientists solve mystery of ‘chemo brain’

It is estimated that as many as half of patients taking cancer drugs experience a decrease in mental sharpness.

9 Oct 2014

Gold Crest Care Center joins the cause to raise awareness for breast cancer

Gold Crest Care Center, one of the leading nursing homes in NYC, has joined the cause to raise awareness for breast cancer education, prevention and treatment. The Bronx, N.Y. facility is dedicated to providing top-notch care for all patients while providing educational services to clients and their families.

9 Oct 2014

New Colombia creates joint venture to produce cannabis and hemp based medicinal products

New Colombia Resources, Inc., a U.S. company with coal and other resource assets in Colombia, is pleased to announce they have formed a joint venture to produce cannabis and hemp based medicinal products in Colombia in association with an indigenous community in Colombia.

9 Oct 2014

GE Healthcare-Glaxo Smith Kline deal to create force in cancer testing

A recently announced deal between GE Healthcare-subsidiary Clarient and Glaxo Smith Kline will create a force in cancer testing, according to Kalorama Information. The healthcare market research publisher tracks companion products, and says that the two entities will form a multi-purpose, data analytics- and companion diagnostics-driven network of laboratories. Kalorama Information recently released a market study, Companion Diagnostics Market, for companion diagnostics such as the drug-test combinations envisioned in this deal.

9 Oct 2014

VAL-083 drug compound shows promise against non-small cell lung cancer

DelMar Pharmaceuticals, Inc., a clinical-stage oncology company, today announced the presentation of promising new data supporting the activity of its lead drug compound, VAL-083, in the treatment of non-small cell lung cancer (NSCLC) at the AACR's New Horizons in Cancer Research: Harnessing Breakthroughs – Targeting Cures. The conference takes place October 9th to 12th in Pudong, Shanghai.

9 Oct 2014

HemoShear completes first-phase development of novel cancer drug discovery platform

HemoShear today announced that it has completed the first phase of development of a novel cancer drug discovery platform that replicates human tumor biology and responds to clinically-relevant drug concentrations.

9 Oct 2014

Isis Pharmaceuticals secures $18 million from GSK to advance ISIS-TTR Rx Phase 2/3 study

Isis Pharmaceuticals, Inc. announced today that it has earned an $18 million milestone payment from GlaxoSmithKline related to the advancement of the Phase 2/3 study of ISIS-TTRRx in patients with familial amyloid polyneuropathy (FAP).

9 Oct 2014

HerStory app helps women with breast cancer to share their voices with other patients

As physicians spend less time with their patients, often as little as 10-15 minutes per appointment, they grow increasingly wary of the limited emotional support they can provide within that time frame.

9 Oct 2014

CytRx begins Phase 1b trial of aldoxorubicin plus gemcitabine in patients with metastatic solid tumors

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced the initiation of enrollment in an open-label Phase 1b clinical trial designed to investigate the preliminary safety and activity of aldoxorubicin plus gemcitabine in subjects with metastatic solid tumors.

9 Oct 2014

Study finds that skin exposure may trigger early peanut allergy in children

Many children may become allergic to peanuts before they first eat them, and skin exposure may be contribute to early sensitization, according to a study in mice led by Mount Sinai researchers and published today in the Journal of Clinical Investigation.

9 Oct 2014

Scientists say fundamental theory about how thymus educates immune police appears to be wrong

A fundamental theory about how our thymus educates our immune police appears to be wrong, scientists say.

9 Oct 2014

Conventional laparoscopy less complicated than robot-assisted surgery for benign gynecologic conditions

For benign gynecologic conditions, robot-assisted surgery involves more complications during surgery and may be significantly more expensive than conventional laparoscopic surgery, according to a study by researchers at Columbia University Medical Center.

9 Oct 2014

University of Luxembourg researchers identify potential new ways to test colorectal cancer

Researchers at the University of Luxembourg have identified potential new ways to test for the first signs of one of the most deadly types of cancer: colorectal cancer. They have found new "biomarkers": molecules whose increased presence or absence in tissue suggests the development of tumorous cells. These indicators could help detect colorectal cancer at an early stage, predict its severity or even offer new treatments.

9 Oct 2014

New model predicts replication rate in genome-wide studies based on SNP characteristics

To reduce false positives when identifying genetic variations associated with human disease through genome-wide association studies (GWAS), Dartmouth researchers have identified nine traits that are not dependent on P values to predict single nucleotide polymorphisms (SNP) reproducibility as reported in Human Genetics on October 2, 2014.

9 Oct 2014

Indian government health insurance program benefits health of the poor

A government program to provide health insurance for catastrophic illness to households below the poverty line in Karnataka, lowered both mortality rates and out-of-pocket expenses for the residents, according to a recent evaluation published in the leading global health journal The BMJ.

9 Oct 2014

Cancer News and Research

Latest Cancer News and Research

UC Berkeley, UCSF researchers team up to create center for neurodegenerative disease research

DU/ER Denim introduces first ever jean with radioactive cell phone protection

VolitionRx announces additional colorectal cancer data at International Conference of Anticancer Research

Study shows rats, mice perform similarly in cognitive tests; offers implications for cognition research

CTCs in blood of metastatic cancer patients give genomic read-out of breast cancer

Neuroscientists solve mystery of ‘chemo brain’

Gold Crest Care Center joins the cause to raise awareness for breast cancer

New Colombia creates joint venture to produce cannabis and hemp based medicinal products

GE Healthcare-Glaxo Smith Kline deal to create force in cancer testing

VAL-083 drug compound shows promise against non-small cell lung cancer

HemoShear completes first-phase development of novel cancer drug discovery platform

Isis Pharmaceuticals secures $18 million from GSK to advance ISIS-TTR Rx Phase 2/3 study

HerStory app helps women with breast cancer to share their voices with other patients

CytRx begins Phase 1b trial of aldoxorubicin plus gemcitabine in patients with metastatic solid tumors

Study finds that skin exposure may trigger early peanut allergy in children

Scientists say fundamental theory about how thymus educates immune police appears to be wrong

Conventional laparoscopy less complicated than robot-assisted surgery for benign gynecologic conditions

University of Luxembourg researchers identify potential new ways to test colorectal cancer

New model predicts replication rate in genome-wide studies based on SNP characteristics

Indian government health insurance program benefits health of the poor

Understanding the DNA Damage Response in Innate Immunity eBook

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Newsletters you may be interested in